Direktorat Registrasi ObatValid

SITAGLIPTIN PHOSPHATE

BPOM Number: GKL2631543417A1
Approved: 6 September 2026
Expiry: 5 September 2031
Form: TABLET SALUT SELAPUT

About This Registration

SITAGLIPTIN PHOSPHATE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2631543417A1. Its current registration status is Valid, with the licence valid until 5 September 2031. The product is registered to PRATAPA NIRMALA - INDONESIA. BPOM first approved this registration in September 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 7 September 2026. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: newaero
Packaging: DUS, 3 BLISTER @ 10 TABLET SALUT SELAPUT
Department: Direktorat Registrasi Obat
Data Last Updated: 7 September 2026

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

PRATAPA NIRMALA - INDONESIA
KOTA TANGERANG
NPWP: 013025754073000
owner
View profile →

Manufacturing Sites

PRATAPA NIRMALA - INDONESIA
KOTA TANGERANG
primary
View profile →

Ingredients (1)

SITAGLIPTIN PHOSPHATE MONOHYDRATE

Market Intelligence

Owner Portfolio: PRATAPA NIRMALA - INDONESIA holds 454 BPOM registrations
Manufacturer Scale: PRATAPA NIRMALA - INDONESIA produces 454 registered products
Update Status: Recently updated (17 days ago)

FDA Cross-Reference

via openFDA

Generic Name: SITAGLIPTIN AND METFORMIN HYDROCHLORIDE
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?